Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators
about
Mechanisms of phthalate ester toxicity in the female reproductive systemSorting out the roles of PPAR alpha in energy metabolism and vascular homeostasisFatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleusRole of Peroxisome Proliferator-Activated Receptors in Inflammation ControlAdvances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and diseaseIs peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?Genetically modified mouse models for the study of nonalcoholic fatty liver diseaseEndocrine-disrupting Chemicals: Review of Toxicological Mechanisms Using Molecular Pathway AnalysisMechanistic considerations for human relevance of cancer hazard of di(2-ethylhexyl) phthalateA human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugsA potent PPARalpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle.Peroxisome proliferator-activated receptor gamma1 (PPAR-gamma1) as a major PPAR in a tissue in which estrogen induces peroxisome proliferation.A reexamination of the PPAR-alpha activation mode of action as a basis for assessing human cancer risks of environmental contaminants.Biology of senescent liver peroxisomes: role in hepatocellular aging and diseaseDifferential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor exPeroxisome proliferator-activated receptors in tumorigenesis: targets of tumour promotion and treatment.Gastrointestinal Cytoprotection by PPARγ Ligands.Effects of the PPARα Agonist and Widely Used Antihyperlipidemic Drug Gemfibrozil on Hepatic Toxicity and Lipid Metabolism.Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesisEffect of wild bitter gourd treatment on inflammatory responses in BALB/c mice with sepsis.Gemfibrozil disrupts lysophosphatidylcholine and bile acid homeostasis via PPARα and its relevance to hepatotoxicity.Peroxisome proliferator-activated receptors and cancer: challenges and opportunitiesA critical role for peroxisomal proliferator-activated receptor-alpha nuclear receptors in the development of cardiomyocyte degeneration and necrosis.Anti-inflammatory effect of Momordica charantia in sepsis mice.PPARalpha agonist-induced rodent tumors: modes of action and human relevance.The truncated splice variant of peroxisome proliferator-activated receptor alpha, PPARα-tr, autonomously regulates proliferative and pro-inflammatory genesRole of oxidative stress in peroxisome proliferator-mediated carcinogenesis.Rodent carcinogenicity of peroxisome proliferators and issues on human relevance.Investigational PPAR-gamma agonists for the treatment of Type 2 diabetes.Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.The PPAR-alpha activator fenofibrate fails to provide myocardial protection in ischemia and reperfusion in pigs.Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer.Interaction Effects of the Leu162Val PPAR α and Pro12Ala PPAR γ 2 Gene Variants with Renal Function in Metabolic Syndrome Population.Genomic profiling in nuclear receptor-mediated toxicity.PPARalpha- and DEHP-Induced CancersNutrigenomics and its Impact on Life Style Associated Metabolic DiseasesRole of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease.Myotoxicity of gemfibrozil in cynomolgus monkey model and its relationship to pharmacokinetic properties.The Critical Role of PPARgamma in Human Malignant Melanoma
P2860
Q24529989-212C249F-7107-4C79-A3B6-E815EB4DEEE8Q24541529-5FC571A8-0B8E-43EB-AC63-438E5C29C897Q24612974-10FEE123-8A55-4D85-95B2-36A9945E3456Q24796541-A99EF52A-1CAE-4889-975A-3E5ABF5A96E7Q24803926-F09107D9-7695-43D8-9BBB-0D6613328FE7Q24812167-DD92019B-8F3E-4257-878A-827519AD6B31Q26865248-0F0CA64F-5181-4685-9F1E-FC9252F4ED8BQ28085684-493565FD-FE87-4921-9B9B-6F2A99593D36Q28256111-A58653DD-74FE-4237-A024-E89AB2967059Q28609826-037066B7-E232-4472-9EF9-62717E8F693DQ31833512-D1CCF6D8-E779-48F4-8C25-52363E218ED6Q32019780-1F2E4531-AC50-4DCC-B699-9470908BD892Q33569334-E6DBB11E-AB3C-4509-AB35-F8D14DE8B545Q33742431-E55F2EAD-B5A4-495E-820D-3056D8F43625Q33952364-FEABDA4F-AE99-491B-BCE4-4551D2ADB432Q34007479-5D6D6EE2-C3D1-4DC0-A545-BE0767CEA4D5Q34159427-71DEE8EB-4BF9-49A8-96B5-38DEAAB9FC73Q34189111-B17B2B11-267E-4CA5-A27F-E25DC94AB25BQ34316470-3345F03B-46F1-484D-A277-090D49684ED4Q34565215-BDDE8F79-B10E-4E35-B714-7C28D294EC72Q34691591-31EDA593-2C66-48B6-B651-7DE384C6DF43Q35079707-D8535067-9F23-4683-A45C-E4274D268886Q35210023-4BBD2AB7-268D-4F97-8234-BEDF11971317Q35222107-1D1B45BE-0D5B-4B11-8CFC-39EEB2408DE1Q35231058-B5D10559-C0CF-40E7-8B63-23145EFEEF8DQ35631058-1D701A54-84E7-4FF8-926E-741999813F3CQ35677612-85216029-E15F-4475-99AA-307788374D75Q36059868-B72BD438-ECA2-41C0-B292-358CCCDFAD4BQ36104056-034FD3FB-FEAB-49A0-B01B-A24E60624A0AQ36512559-45FFDDD5-53FD-4BCC-8055-7935F6BAB81FQ36586072-4878CEFA-943F-4767-BA3D-8FB3EFCCFA0DQ36787467-E2522CB2-DDE4-4329-8523-31CF3CC9EDB4Q36795404-10216B0B-62AE-4B93-AFD0-25545AF706DAQ36830957-AFC63D85-41EC-4CE4-8C7E-1C16A664EE8BQ36846922-E774BC37-7903-4222-B8C8-03FE3BB6F455Q36857053-13EDF05A-6A2A-42FC-ADBF-8923CA6FEF46Q36906565-8FF459C6-95CD-43E4-A6AA-0B262BC5F905Q37051264-DEF62ADB-86F5-4B82-BFD4-90B0A3F03E04Q37114391-CC4723C9-E827-4878-9B50-9D7AF570630CQ37165194-A06AE4AF-B35C-44FA-83E5-64312363C688
P2860
Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators
description
1994 nî lūn-bûn
@nan
1994 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Human and rat peroxisome proli ...... ponsiveness to PPAR activators
@ast
Human and rat peroxisome proli ...... ponsiveness to PPAR activators
@en
Human and rat peroxisome proli ...... ponsiveness to PPAR activators
@nl
type
label
Human and rat peroxisome proli ...... ponsiveness to PPAR activators
@ast
Human and rat peroxisome proli ...... ponsiveness to PPAR activators
@en
Human and rat peroxisome proli ...... ponsiveness to PPAR activators
@nl
prefLabel
Human and rat peroxisome proli ...... ponsiveness to PPAR activators
@ast
Human and rat peroxisome proli ...... ponsiveness to PPAR activators
@en
Human and rat peroxisome proli ...... ponsiveness to PPAR activators
@nl
P2093
P3181
P1476
Human and rat peroxisome proli ...... ponsiveness to PPAR activators
@en
P2093
P304
P3181
P356
10.1016/0960-0760(94)90089-2
P407
P577
1994-11-01T00:00:00Z